House votes to repeal the IPAB and enact meaningful liability reform
The AADA has been steadfast in communicating with Congress about the negative consequences that the unelected IPAB would have on the specialty of dermatology and its patients. AADA recently urged congressional leadership to swiftly vote on repeal legislation. Both IPAB repeal and medical liability reform are legislative priorities of the AADA and passage of these bills in the House of Representatives is a significant step forward in ensuring that patients across the country continue to have access to quality dermatologic care.
AADA urges support for cancer programs in 2013 appropriations funding
On March 19, the AADA, along with other One Voice Against Cancer member organizations, sent a letter to the House Appropriations Committee urging Congress to support funding for cancer prevention and control programs at the Centers for Disease Control and Prevention (CDC) at least at their FY2010 levels, and asking that cancer programs remain as categorical budget lines that the Administration’s FY2013 budget proposes to consolidate. Additionally, these organizations sent a letter to the Senate Appropriations Committee urging support of a National Institutes of Health budget of at least $32.7 billion, including $5.36 billion for the National Cancer Institute in the FY2013 Labor-HHS-Education appropriations bill.
CMS announces 5010 enforcement delay
AADA continues dialogue with FDA on drug shortages
The AADA is working with staff from the FDA to identify the source of the problem in obtaining cantharidin and possible solutions. A July 2011 Dermatology World article explored issues surrounding access to this treatment modality.
The AADA conducted an informal survey of members to better understand the number of dermatology drugs currently in shortage. The survey showed that approximately 70 percent of the 61 respondents are experiencing a shortage of tetracycline. Additional shortages include lidocaine, bleomycin, and TriLuma cream. Please contact Amanda Grimm, senior specialist, Regulatory Policy at firstname.lastname@example.org with your drug shortage experiences.
Idaho and Vermont advance indoor tanning bills
Dr. Siegel issues million dollar challenge
SkinPAC’s political purpose is to solicit and receive contributions to be used to make political campaign expenditures to those candidates for federal elective office, and other federal political committees, who demonstrate understanding and interest in the views and goals of the American Academy of Dermatology Association.
Contributions to SkinPAC are not deductible as charitable contributions for federal income tax purposes. SkinPAC cannot accept contributions from corporate accounts. All AADA members have the right to refuse to contribute without reprisal. Federal law prohibits us from accepting contributions from foreign nationals. Federal law requires us to use our best efforts to collect and report the name, physical address, occupation, and the name of the employer of individuals whose contributions exceed $200 in a calendar year.